Concepedia

Nicolás Meyer

NM

Statistics

Publications

109

Citations

13K

H-Index

44

Active since

2003

Affiliations

Université Toulouse III - Paul Sabatier(Current)

Inserm

Centre Hospitalier Universitaire de Toulouse

Institut universitaire du cancer de Toulouse Oncopole

Hôpital Larrey

Nicolás Meyer is an author at Université Toulouse III - Paul Sabatier specializing in medicine, oncology, and immunology.

ORCID

Top concepts

Publications per year

2003–2025

109

Publications

109

Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma

Michael A. Postow, Jason Chesney, Anna C. Pavlick et al. · New England Journal of Medicine · 2015 · 2.7K citations · Full text

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma

Jeffrey S. Weber, Mario Mandalà, Michele Del Vecchio et al. · New England Journal of Medicine · 2017 · 2.1K citations · Full text

Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial

F. Stephen Hodi, Jason Chesney, Anna C. Pavlick et al. · The Lancet Oncology · 2016 · 967 citations

, , +8

Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial

Michael A. Davies, Philippe Saïag, Caroline Robert et al. · The Lancet Oncology · 2017 · 759 citations · Full text

, , +5

Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients

Myriam Delaunay, J. Cadranel, Amélie Lusque et al. · European Respiratory Journal · 2017 · 416 citations · Full text

Rows per page

1–5 of 109